Ang-II, a well-recognized clinical determinant in reversing maladaptive cardiac hypertrophy, induces cardiomyocyte enlargement and accelerates fibroblast differentiation through its surface angiotensin receptor (ATR) (Lijnen et al., 2001; Ainscough et al., 2009) (Figure 2). This evidence concerns the gene AGT and cardiac hypertrophy.